• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CYP450 通过增加 20-HETE 活性在β-地中海贫血小鼠模型中介导活性氧的产生。

CYP450 Mediates Reactive Oxygen Species Production in a Mouse Model of β-Thalassemia through an Increase in 20-HETE Activity.

机构信息

Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon.

Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut 1107 2020, Lebanon.

出版信息

Int J Mol Sci. 2021 Jan 23;22(3):1106. doi: 10.3390/ijms22031106.

DOI:10.3390/ijms22031106
PMID:33498614
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7865490/
Abstract

Oxidative damage by reactive oxygen species (ROS) is one of the main contributors to cell injury and tissue damage in thalassemia patients. Recent studies suggest that ROS generation in non-transfusion-dependent (NTDT) patients occurs as a result of iron overload. Among the different sources of ROS, the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase family of enzymes and cytochrome P450 (CYP450) have been proposed to be major contributors for oxidative stress in several diseases. However, the sources of ROS in patients with NTDT remain poorly understood. In this study, mice, a mouse model for β-thalassemia, were used. These mice exhibit an unchanged or decreased expression of the major NOX isoforms, NOX1, NOX2 and NOX4, when compared to their C57BL/6 control littermates. However, a significant increase in the protein synthesis of CYP4A and CYP4F was observed in the mice when compared to the C57BL/6 control mice. These changes were paralleled by an increased production of 20-hydroxyeicosatetraenoic acid (20-HETE), a CYP4A and CYP4F metabolite. Furthermore, these changes corroborate with onset of ROS production concomitant with liver injury. To our knowledge, this is the first report indicating that CYP450 4A and 4F-induced 20-HETE production mediates reactive oxygen species overgeneration in mice through an NADPH-dependent pathway.

摘要

活性氧(ROS)的氧化损伤是导致地中海贫血患者细胞损伤和组织损伤的主要因素之一。最近的研究表明,非输血依赖型(NTDT)患者的 ROS 产生是由于铁过载所致。在不同的 ROS 来源中,烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶家族的酶和细胞色素 P450(CYP450)被认为是几种疾病中氧化应激的主要贡献者。然而,NTDT 患者的 ROS 来源仍知之甚少。在这项研究中,使用了一种β地中海贫血小鼠模型。与 C57BL/6 对照同窝仔相比,这些小鼠的主要 NOX 同工型(NOX1、NOX2 和 NOX4)的表达不变或降低。然而,与 C57BL/6 对照小鼠相比,在 小鼠中观察到 CYP4A 和 CYP4F 的蛋白合成显著增加。这些变化伴随着 CYP4A 和 CYP4F 代谢物 20-羟二十碳四烯酸(20-HETE)的产生增加。此外,这些变化与 ROS 产生与肝损伤同时发生相吻合。据我们所知,这是第一个表明 CYP450 4A 和 4F 诱导的 20-HETE 产生通过 NADPH 依赖性途径介导 小鼠中活性氧过度产生的报告。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab07/7865490/820edddab0f4/ijms-22-01106-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab07/7865490/d630249b3ddf/ijms-22-01106-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab07/7865490/9aae50a549fc/ijms-22-01106-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab07/7865490/1b100eca9c61/ijms-22-01106-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab07/7865490/2cf4aa56865f/ijms-22-01106-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab07/7865490/0c1b3cad7122/ijms-22-01106-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab07/7865490/820edddab0f4/ijms-22-01106-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab07/7865490/d630249b3ddf/ijms-22-01106-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab07/7865490/9aae50a549fc/ijms-22-01106-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab07/7865490/1b100eca9c61/ijms-22-01106-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab07/7865490/2cf4aa56865f/ijms-22-01106-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab07/7865490/0c1b3cad7122/ijms-22-01106-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab07/7865490/820edddab0f4/ijms-22-01106-g006.jpg

相似文献

1
CYP450 Mediates Reactive Oxygen Species Production in a Mouse Model of β-Thalassemia through an Increase in 20-HETE Activity.CYP450 通过增加 20-HETE 活性在β-地中海贫血小鼠模型中介导活性氧的产生。
Int J Mol Sci. 2021 Jan 23;22(3):1106. doi: 10.3390/ijms22031106.
2
Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases.糖尿病中足细胞损伤的机制:细胞色素P450和NADPH氧化酶的作用
Diabetes. 2009 May;58(5):1201-11. doi: 10.2337/db08-1536. Epub 2009 Feb 10.
3
Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.烟酰胺腺嘌呤二核苷酸磷酸氧化酶在实验性肝纤维化中的作用:GKT137831 作为一种新型潜在治疗药物。
Hepatology. 2012 Dec;56(6):2316-27. doi: 10.1002/hep.25938.
4
The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice.烟酰胺腺嘌呤二核苷酸磷酸氧化酶(NOX)同源物 NOX1 和 NOX2/gp91(phox) 介导小鼠肝纤维化。
Hepatology. 2011 May;53(5):1730-41. doi: 10.1002/hep.24281.
5
Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation.NOX1或NOX4的缺失通过抑制肝星状细胞激活预防小鼠肝脏炎症和纤维化。
PLoS One. 2015 Jul 29;10(7):e0129743. doi: 10.1371/journal.pone.0129743. eCollection 2015.
6
Paraoxonase 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidase.对氧磷酶 2 可减少肾脏产生的活性氧,降低血压,并介导多巴胺 D2 受体抑制 NADPH 氧化酶。
Free Radic Biol Med. 2012 Aug 1;53(3):437-46. doi: 10.1016/j.freeradbiomed.2012.05.015. Epub 2012 May 23.
7
Vascular characterization of mice with endothelial expression of cytochrome P450 4F2.内皮细胞表达细胞色素 P450 4F2 的小鼠的血管特征。
FASEB J. 2014 Jul;28(7):2915-31. doi: 10.1096/fj.13-241927. Epub 2014 Mar 25.
8
Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models.NOX 异构体在血管病理生理学中的作用:来自转基因和基因敲除小鼠模型的见解。
Redox Rep. 2010;15(2):50-63. doi: 10.1179/174329210X12650506623401.
9
Reduced PU.1 expression underlies aberrant neutrophil maturation and function in β-thalassemia mice and patients.PU.1 表达降低导致β-地中海贫血小鼠和患者中性粒细胞成熟和功能异常。
Blood. 2017 Jun 8;129(23):3087-3099. doi: 10.1182/blood-2016-07-730135. Epub 2017 Mar 21.
10
Cytochrome P450 enzymes but not NADPH oxidases are the source of the NADPH-dependent lucigenin chemiluminescence in membrane assays.在膜分析中,细胞色素P450酶而非NADPH氧化酶是NADPH依赖的光泽精化学发光的来源。
Free Radic Biol Med. 2017 Jan;102:57-66. doi: 10.1016/j.freeradbiomed.2016.11.019. Epub 2016 Nov 15.

引用本文的文献

1
[Application of Animal Models in Research on Hypoxia-Related Diseases].[动物模型在缺氧相关疾病研究中的应用]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025 Mar 20;56(2):331-338. doi: 10.12182/20250360101.
2
Exploring the bone marrow micro environment in thalassemia patients: potential therapeutic alternatives.探讨地中海贫血患者骨髓微环境:潜在的治疗新选择。
Front Immunol. 2024 Aug 5;15:1403458. doi: 10.3389/fimmu.2024.1403458. eCollection 2024.
3
METTL16 participates in haemoglobin H disease through m6A modification.METTL16 通过 m6A 修饰参与血红蛋白 H 病。

本文引用的文献

1
Changing patterns in the epidemiology of β-thalassemia.β地中海贫血流行病学模式的变化
Eur J Haematol. 2020 Dec;105(6):692-703. doi: 10.1111/ejh.13512. Epub 2020 Sep 21.
2
Metformin and Probiotics in the Crosstalk between Colitis-Associated Colorectal Cancer and Diabetes in Mice.二甲双胍与益生菌在小鼠结肠炎相关结直肠癌和糖尿病相互作用中的研究
Cancers (Basel). 2020 Jul 10;12(7):1857. doi: 10.3390/cancers12071857.
3
Targeting the NADPH Oxidase-4 and Liver X Receptor Pathway Preserves Schwann Cell Integrity in Diabetic Mice.靶向 NADPH 氧化酶-4 和肝 X 受体通路可保护糖尿病小鼠雪旺细胞的完整性。
PLoS One. 2024 Aug 1;19(8):e0306043. doi: 10.1371/journal.pone.0306043. eCollection 2024.
4
Reducing Oxidative Stress-Mediated Alcoholic Liver Injury by Multiplexed RNAi of , and .通过对……的多重RNA干扰减轻氧化应激介导的酒精性肝损伤
Biomedicines. 2024 Jul 6;12(7):1505. doi: 10.3390/biomedicines12071505.
5
The interactions between ineffective erythropoiesis and ferroptosis in β-thalassemia.β地中海贫血中无效红细胞生成与铁死亡之间的相互作用。
Front Physiol. 2024 Feb 26;15:1346173. doi: 10.3389/fphys.2024.1346173. eCollection 2024.
6
Cigarette Smoke-Induced Reactive Oxygen Species Formation: A Concise Review.香烟烟雾诱导的活性氧生成:简要综述。
Antioxidants (Basel). 2023 Sep 7;12(9):1732. doi: 10.3390/antiox12091732.
7
Bioinorganic Modulators of Ferroptosis: A Review of Recent Findings.生物无机铁死亡调节剂:最新研究进展综述。
Int J Mol Sci. 2023 Feb 11;24(4):3634. doi: 10.3390/ijms24043634.
8
Cytochrome P450 enzymes mediated by DNA methylation is involved in deoxynivalenol-induced hepatoxicity in piglets.由DNA甲基化介导的细胞色素P450酶参与脱氧雪腐镰刀菌烯醇诱导的仔猪肝毒性。
Anim Nutr. 2022 Feb 21;9:269-279. doi: 10.1016/j.aninu.2021.11.009. eCollection 2022 Jun.
9
The Functions of Cytochrome P450 ω-hydroxylases and the Associated Eicosanoids in Inflammation-Related Diseases.细胞色素P450 ω-羟化酶及相关类花生酸在炎症相关疾病中的作用
Front Pharmacol. 2021 Sep 14;12:716801. doi: 10.3389/fphar.2021.716801. eCollection 2021.
Diabetes. 2020 Mar;69(3):448-464. doi: 10.2337/db19-0517. Epub 2019 Dec 27.
4
Minihepcidins improve ineffective erythropoiesis and splenomegaly in a new mouse model of adult β-thalassemia major.小分子肝酶肽可改善成人重型β地中海贫血新模型中的无效红细胞生成和脾肿大。
Haematologica. 2020 Jul;105(7):1835-1844. doi: 10.3324/haematol.2018.212589. Epub 2019 Oct 3.
5
Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis.转化生长因子-β诱导的肝纤维化和肝癌发生中的细胞可塑性
Front Oncol. 2018 Sep 10;8:357. doi: 10.3389/fonc.2018.00357. eCollection 2018.
6
How I manage medical complications of β-thalassemia in adults.成人β-地中海贫血症的医学并发症管理方法。
Blood. 2018 Oct 25;132(17):1781-1791. doi: 10.1182/blood-2018-06-818187. Epub 2018 Sep 11.
7
Molecular basis of the counteraction by calcium channel blockers of cyclosporine nephrotoxicity.钙通道阻滞剂拮抗环孢素肾毒性的分子基础。
Am J Physiol Renal Physiol. 2018 Sep 1;315(3):F572-F582. doi: 10.1152/ajprenal.00275.2017. Epub 2018 May 16.
8
The Evolving Spectrum of the Epidemiology of Thalassemia.地中海贫血流行病学的演变范围
Hematol Oncol Clin North Am. 2018 Apr;32(2):165-175. doi: 10.1016/j.hoc.2017.11.008.
9
Iron overload in hematological disorders.血液系统疾病中的铁过载
Presse Med. 2017 Dec;46(12 Pt 2):e296-e305. doi: 10.1016/j.lpm.2017.10.007. Epub 2017 Nov 22.
10
Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis.靶向转化生长因子-β介导的SMAD信号通路预防纤维化
Front Pharmacol. 2017 Jul 14;8:461. doi: 10.3389/fphar.2017.00461. eCollection 2017.